VANCOUVER, February 5th, 2021 - Covalent is delighted to announce a technical partnership with Injective Protocol, a fully decentralized and robust cross-chain DEX supporting a diverse array of derivatives including CFDs, perpetual swaps and more. A pioneer in the space, Injective Protocol aims to bring power back to the people by enabling truly free and decentralized trading for everyone.
At the heart of this partnership is the user. By partnering with Covalent, Injective Protocol will have access to real-time and granular blockchain data through the enterprise-grade Covalent API. Such data will not only provide valuable insight into the domain of DeFi, but traders will be able to export their trading data with full historical context which will allow benchmarking of investor performance and record-keeping as evidence for tax purposes. Ultimately, the Injective Protocol user experience will be enhanced.
A core backbone to Injective's layer-2 derivatives platform is the Injective Chain which hosts a fully decentralized orderbook, trade execution coordinator, EVM execution environment, and bi-directional token bridge to Ethereum. Once live, Covalent will be indexing the Injective Chain. By enabling instant access to the data on the Injective Chain, Injective Protocol will be able to bolster the capabilities of the platform through, for example, analytical dashboards and terminals while again, improving the user experience.
Quote from Ganesh, Covalent's CEO
“ At Covalent, we have a lot of admiration for Injective Protocol given the decentralized approach they have taken in building its DEX. Now, as a major component of Injective’s ecosystem, Covalent looks forward to mutually building our respective communities and elevating the DeFi user experience to new levels.
Quote from Eric Chen, Injective Protocol CEO
“ Injective is excited to be working with the team at Covalent. Proper data feeds are an integral component of building a robust derivatives DEX, so this integration can aid in bolstering our ecosystem further.
About Injective Protocol
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective Protocol is backed by a prominent group of stakeholders including Pantera Capital, one of the most renowned venture capital firms in the world, and the leading cryptocurrency exchange, Binance.
Telegram: Injective Protocol